Drug and Therapeutics Committees - A Practical Guide
(2003; 155 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentAcronyms and abbreviations
View the documentPreface
Open this folder and view contents1. Introduction
Open this folder and view contents2.Structure and organization of a drug and therapeutics committee
Open this folder and view contents3. Managing the formulary process
Open this folder and view contents4.Assessing new medicines
Open this folder and view contents5.Ensuring medicine safety and quality
Close this folder6.Tools to investigate the use of medicines
View the document6.1 Stepwise approach to investigating the use of medicines
View the document6.2 Analysis of aggregate medicine use data
View the document6.3 WHO/INRUD drug use indicators for health facilities
View the document6.4 Qualitative methods to investigate causes of problems of medicine use
View the document6.5 Drug use evaluation (DUE) (drug utilization review)
View the documentAnnex 6.1 Defined daily doses (DDD) of some common medicines
View the documentAnnex 6.2 DUE criteria on data collection form for amikacin
Open this folder and view contents7.Promoting the rational use of medicines
Open this folder and view contents8.Antimicrobials and injections
Open this folder and view contents9. Getting started
View the documentGlossary1
View the documentReferences
View the documentFurther reading
View the documentUseful addresses and websites
View the documentBack cover
 

6.Tools to investigate the use of medicines

Summary

The first step to addressing problems of irrational use of medicines is to measure the problem, analyse it and understand the causes underlying it. There are four main methods, all of which should be regularly used by DTCs.

Aggregate data methods involve data that do not relate to individual patients and can be collected relatively easily. Methods such as ABC analysis, VEN analysis and DDD methodology are used to identify broad problem areas in drug use.

Drug indicators studies involve collecting data at the level of the individual patient but do not usually include sufficient information to make judgements about drug appropriateness for diagnosis. Such data can be collected by non-prescribers and can be used to identify problem areas in medicine use and patient care, and evaluate interventions designed to correct the problems identified.

Qualitative methods such as focus group discussion, in-depth interview, structured observation and structured questionnaires are useful for identifying why drug use problems occur.

Drug use evaluation is a system of ongoing criteria-based evaluation of drug use that will help to ensure appropriate use at the individual patient level. This method involves the detailed analysis of individual patient data.

to previous section to next section
 

Last updated: May 3, 2013